Oncotelic Therapeutics, Inc.·4

Jun 16, 12:00 PM ET

Trieu Vuong 4

4 · Oncotelic Therapeutics, Inc. · Filed Jun 16, 2023

Insider Transaction Report

Form 4
Period: 2023-06-14
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2023-06-14$0.03/sh+400,000$13,04091,444,217 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    6,872,529
  • Common Stock

    (indirect: By Autotelic, Inc.)
    16,780,384

Documents

1 file
  • 4
    ownership.xmlPrimary